US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
BT

BTCY

Stock Biotricity, Inc.
$0.08660-6.38% today

Healthcare · US

52-week $0.09 $0.75
Open in terminal Compare
Alert
Sharia status
NOT COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25
Purification 100.00%
Methodology breakdown (0/7 compliant)
AAOIFI ● REVIEW
Debt ratio no data
Investments ratio no data
Non permissible income ratio no data
Usmani ● REVIEW
Debt ratio no data
Investments ratio no data
Nonliquid assets ratio no data
Non permissible income ratio no data
Net liquid assets no data
Dow Jones ● REVIEW
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
S&P Shariah ● REVIEW
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
MSCI ● REVIEW
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
MSCI M ● REVIEW
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
FTSE ● REVIEW
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data

Business activity could not be assessed — classifier temporarily unavailable (rate limit or outage) — not a real assessment, try again later

ℹ️ Ratios above can still show Pass — business-activity screening itself couldn't run, and it's a hard gate a ratio pass can't substitute for.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 3 timeframes bullish · 100.0% aligned
VWAPPrice below VWAP ($0.09)
VolumeRelative volume 9.7× the 20-day average
Momentum10-day rate of change -16.3%

Biotricity, Inc. (BTCY) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Institutional own.
1.2%
of shares
Momentum (10d)
-16.3%
rate of change
SMC grade
D · 38
100.0% aligned
NON-COMPLIANT
Sharia compliance
100.00%
Purification ratio
D · 38
SMC grade — 100.0% timeframe alignment
-16.3%
Rate of change (10d)
1.2%
Institutional ownership

🕌 In-house Compliance Research

Research only, not the primary verdict above — computed from SEC EDGAR filings and business-activity classification, same as the Discord bot's !halal command.

Business activity: could not be assessed

classifier temporarily unavailable (rate limit or outage) — not a real assessment, try again later

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio no data
Investments ratio no data
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio no data
Investments ratio no data
Nonliquid assets ratio no data
Non permissible income ratio no data
Net liquid assets no data
Dow Jones Islamic Market (% of 24-mo avg market cap) — Unverified
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
S&P Shariah Indices (% of 36-mo avg market cap) — Unverified
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
MSCI Islamic Index (% of total assets) — Unverified
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
MSCI Islamic M-Series (% of 36-mo avg market cap) — Unverified
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data
FTSE Shariah Global Equity Index Series (% of total assets) — Unverified
Debt ratio no data
Cash and interest ratio no data
Receivables ratio no data
Non permissible income ratio no data

Combined verdict: AAOIFI Needs Review Usmani Needs Review Dow Jones Islamic Needs Review S&P Shariah Needs Review MSCI Islamic Needs Review MSCI Islamic M Needs Review FTSE Shariah Needs Review

ℹ️ Every methodology's ratios above may show Pass, but the combined verdict still reads Needs Review because business-activity screening itself couldn't run (classifier temporarily unavailable (rate limit or outage) — not a real assessment, try again later) — it's a hard gate, so a real ratio pass can't substitute for it. Re-check this page later once that's resolved.

The three ratios

Computed from the company's own filing, measured against market cap — the AAOIFI basis. Other standards move both the line and the denominator, which is what the breakdown above shows.

Debt ratio not measured
Investments ratio not measured
Non permissible income ratio not measured
Basis Complete

The numbers the ratios are built from

Read from BTCY's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period not measured
Interest-bearing debtBorrowings — which definition was stored is not recorded not measured
Cash and interest-bearing securitiesCash, equivalents and marketable securities not measured
Total assetsBalance sheet total not measured
Market capDenominator for AAOIFI not measured
36-month average market capDenominator for S&P Shariah and MSCI M-Series not measured
24-month average market capDenominator for Dow Jones Islamic Market $7.2M
Non-permissible revenueInterest and excluded income not measured

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for BTCY. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded Every scan since tracking began has re-derived the same verdict for BTCY.

Tracked since 2026-09-07.

0.710.550.400.240.092025-09-182026-03-192026-09-16

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.07
S2
0.08
S1
0.09
PIVOT
0.10
R1
0.11
R2
0.12
R3
0.13

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
0.06 0.12
±34.81% from 0.09, made 2026-09-10 · resolves 2026-09-17
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 49575 forecast(s) are currently open and will be scored automatically when their horizon expires.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)42.00NEUTRAL
Stochastic %K (14)10.09BUY
CCI (20)-98.20NEUTRAL
Williams %R (14)-89.91BUY
MACD (12,26,9)-0.00SELL
ROC (10)-10.63SELL
Momentum (10)-0.01SELL
EMA (10)0.10SELL
SMA (10)0.10SELL
EMA (20)0.10SELL
SMA (20)0.11SELL
EMA (30)0.11SELL
SMA (30)0.11SELL
EMA (50)0.11SELL
SMA (50)0.11SELL
EMA (100)0.15SELL
SMA (100)0.14SELL
EMA (200)0.24SELL
SMA (200)0.21SELL

About Biotricity, Inc.

Healthcare · Medical Devices

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

biotricity.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 38
⏱ 15-Min BEARISH 25
⏲ 5-Min BEARISH 75

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-0.00
MACD (no fresh cross)

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

Key Statistics

From the nightly market snapshot, shown so the verdict sits beside the numbers it does not depend on.

Health Care
Sector · Health Care
$2M
Market cap
677.1
P/B
$-0.10
EPS (TTM)
$0.71
Revenue / share
13.4%
Revenue growth (YoY)
-16.4%
Net margin
81.5%
Gross margin
-354.7%
Return on equity
0.00
Debt / equity
0.16
Current ratio
1.04
Beta
42
RSI
9/10
Risk score

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.